BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10064062)

  • 1. Inhibition of protein kinase C alpha expression by antisense RNA in transfected Jurkat cells.
    López-Lago MA; Freire-Moar J; Barja P
    Eur J Immunol; 1999 Feb; 29(2):466-76. PubMed ID: 10064062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inhibition of protein kinase Cbeta expression by antisense RNA affects the activation of Jurkat T lymphoma cells.
    Cervino MC; Lopez-Lago MA; Vinuela JE; Barja P
    J Biol Regul Homeost Agents; 2010; 24(3):273-85. PubMed ID: 20846475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phorbol ester synergizes with Ca2+ ionophore in activation of protein kinase C (PKC)alpha and PKC beta isoenzymes in human T cells and in induction of related cellular functions.
    Altman A; Mally MI; Isakov N
    Immunology; 1992 Jul; 76(3):465-71. PubMed ID: 1388136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of expression of protein kinase C alpha by antisense cDNA inhibits phorbol ester-mediated arachidonate release.
    Godson C; Bell KS; Insel PA
    J Biol Chem; 1993 Jun; 268(16):11946-50. PubMed ID: 7685027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells.
    Chwae YJ; Chang MJ; Park SM; Yoon H; Park HJ; Kim SJ; Kim J
    J Immunol; 2002 Oct; 169(7):3726-35. PubMed ID: 12244166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation events mediated by protein kinase C alpha and epsilon participate in regulation of tau steady-state levels and generation of certain "Alzheimer-like" phospho-epitopes.
    Boyce JJ; Shea TB
    Int J Dev Neurosci; 1997 Jun; 15(3):295-307. PubMed ID: 9253654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of expression of PKC-alpha by antisense mRNA is associated with diminished cell growth and inhibition of amylase secretion by AR4-2J cells.
    Zhang X; Wen J; Aletta JM; Rubin RP
    Exp Cell Res; 1997 May; 233(1):225-31. PubMed ID: 9184091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of protein kinase C alpha overexpression on A7r5 smooth muscle cell proliferation and differentiation.
    Wang S; Desai D; Wright G; Niles RM; Wright GL
    Exp Cell Res; 1997 Oct; 236(1):117-26. PubMed ID: 9344591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism.
    Chen CC; Wang JK; Lin SB
    J Immunol; 1998 Dec; 161(11):6206-14. PubMed ID: 9834107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of chemosensitivity in human colon carcinoma cells by downregulating protein kinase C alpha expression.
    Chakrabarty S; Huang S
    J Exp Ther Oncol; 1996 Jul; 1(4):218-21. PubMed ID: 9414406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional effects of overexpression of protein kinase C-alpha, -beta, -delta, -epsilon, and -eta in the mast cell line RBL-2H3.
    Chang EY; Szallasi Z; Acs P; Raizada V; Wolfe PC; Fewtrell C; Blumberg PM; Rivera J
    J Immunol; 1997 Sep; 159(6):2624-32. PubMed ID: 9300681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.
    Ways DK; Kukoly CA; deVente J; Hooker JL; Bryant WO; Posekany KJ; Fletcher DJ; Cook PP; Parker PJ
    J Clin Invest; 1995 Apr; 95(4):1906-15. PubMed ID: 7706498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective post-transcriptional down-regulation of protein kinase C isoenzymes in leukemic T cells chronically treated with phorbol ester.
    Isakov N; McMahon P; Altman A
    J Biol Chem; 1990 Feb; 265(4):2091-7. PubMed ID: 2298741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of mRNAs encoding protein kinase C isoenzymes in activated human B cells.
    Brick-Ghannam C; Ericson ML; Schelle I; Charron D
    Hum Immunol; 1994 Nov; 41(3):216-24. PubMed ID: 7868377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C beta 1 and protein kinase C beta 2 activate p57 mitogen-activated protein kinase and block differentiation in colon carcinoma cells.
    Sauma S; Yan Z; Ohno S; Friedman E
    Cell Growth Differ; 1996 May; 7(5):587-94. PubMed ID: 8732668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense expression of protein kinase C alpha inhibits the growth and tumorigenicity of human glioblastoma cells.
    Ahmad S; Mineta T; Martuza RL; Glazer RI
    Neurosurgery; 1994 Nov; 35(5):904-8; discussion 908-9. PubMed ID: 7838340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of protein kinase C isoform proteins in phorbol ester-stimulated Jurkat T lymphoma cells.
    Tsutsumi A; Kubo M; Fujii H; Freire-Moar J; Turck CW; Ransom JT
    J Immunol; 1993 Mar; 150(5):1746-54. PubMed ID: 8436813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C isozymes in progressively transformed rat embryo fibroblasts.
    Liao L; Ramsay K; Jaken S
    Cell Growth Differ; 1994 Nov; 5(11):1185-94. PubMed ID: 7848920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of protein kinase C alpha and beta1 has distinct effects on bovine aortic endothelial cell growth.
    Rosales OR; Isales CM; Bhargava J
    Cell Signal; 1998 Sep; 10(8):589-97. PubMed ID: 9794258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKC-θ is a negative regulator of TRAIL-induced and FADD-mediated apoptotic spectrin aggregation.
    Michalczyk I; Toporkiewicz M; Dubielecka PM; Chorzalska A; Sikorski AF
    Folia Histochem Cytobiol; 2016; 54(1):1-13. PubMed ID: 27094638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.